89 related articles for article (PubMed ID: 17569588)
21. The importance of CD34+/CD33- cells in platelet engraftment after intensive therapy for cancer patients given peripheral blood stem cell rescue.
Millar BC; Millar JL; Shepherd V; Blackwell P; Porter H; Cunningham D; Judson I; Treleaven J; Powles RL; Catovsky D
Bone Marrow Transplant; 1998 Sep; 22(5):469-75. PubMed ID: 9733270
[TBL] [Abstract][Full Text] [Related]
22. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
Kasow KA; Sims-Poston L; Eldridge P; Hale GA
Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
[TBL] [Abstract][Full Text] [Related]
23. Extensive early apoptosis in frozen-thawed CD34-positive stem cells decreases threshold doses for haematological recovery after autologous peripheral blood progenitor cell transplantation.
de Boer F; Dräger AM; Pinedo HM; Kessler FL; van der Wall E; Jonkhoff AR; van der Lelie J; Huijgens PC; Ossenkoppele GJ; Schuurhuis GJ
Bone Marrow Transplant; 2002 Feb; 29(3):249-55. PubMed ID: 11859398
[TBL] [Abstract][Full Text] [Related]
24. Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.
Klaus J; Herrmann D; Breitkreutz I; Hegenbart U; Mazitschek U; Egerer G; Cremer FW; Lowenthal RM; Huesing J; Fruehauf S; Moehler T; Ho AD; Goldschmidt H
Eur J Haematol; 2007 Jan; 78(1):21-8. PubMed ID: 17042762
[TBL] [Abstract][Full Text] [Related]
25. A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 x 10(6) CD34+ cells/kg be considered the minimum threshold?
Singhal S; Powles R; Treleaven J; Kulkarni S; Sirohi B; Horton C; Millar B; Shepherd V; Tait D; Saso R; Rowland A; Long S; Mehta J
Bone Marrow Transplant; 2000 Sep; 26(5):489-96. PubMed ID: 11019837
[TBL] [Abstract][Full Text] [Related]
26. Role of the CD34+ 38- cells in posttransplant hematopoietic recovery.
Hénon P; Sovalat H; Bourderont D; Ojeda-Uribe M; Arkam Y; Wunder E; Raidot JP; Husseini F; Audhuy B
Stem Cells; 1998; 16 Suppl 1():113-22. PubMed ID: 11012153
[TBL] [Abstract][Full Text] [Related]
27. Factors predicting peripheral blood progenitor cell collection from pediatric donors for allogeneic transplantation.
Díaz MA; Sevilla J; de la Rubia J; Verdeguer A; Espigado I; Vicent MG; Pascual MJ; Zamora C; Arrieta R; Serrano D; del Cañizo C; Arbona C; de Arriba F; Bargay J; Brunet S; Sanz MA
Haematologica; 2003 Aug; 88(8):919-22. PubMed ID: 12935980
[TBL] [Abstract][Full Text] [Related]
28. Kinetics and immunophenotypic characterization of circulating hematopoietic progenitor cells after peripheral blood stem cell transplantation.
Albo C; de la Fuente J; Ares C; Alonso C; Feteira E
Haematologica; 2004 Jul; 89(7):845-51. PubMed ID: 15257937
[TBL] [Abstract][Full Text] [Related]
29. CD34+ cell dose and CD33- subsets: collection and engraftment kinetics in autologous peripheral blood stem cells transplantation.
Sampol Mayol A; Besalduch Vital J; Galmés Llodrá A; Bargay Lleonart J; Matamoros Flori N; Morey Sureda M; Novo García A; Mascaró Riera M; Gonzaléz Bach E; Martínez García P
Haematologica; 1998 Jun; 83(6):489-95. PubMed ID: 9676020
[TBL] [Abstract][Full Text] [Related]
30. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
[TBL] [Abstract][Full Text] [Related]
31. [Autologous transplantation of hematopoietic precursor cells following CD34 selection].
Tichelli A; Gratwohl A; Bargetzi M; Nissen C; Wernli M; Herrmann R; Orth B; Signer E; Speck B
Schweiz Med Wochenschr; 1996 Feb; 126(6):201-6. PubMed ID: 8720723
[TBL] [Abstract][Full Text] [Related]
32. Enumeration of CD34+ hematopoietic progenitor cells for clinical transplantation: comparison of three different methods.
Venditti A; Battaglia A; Del Poeta G; Buccisano F; Maurillo L; Tamburini A; Del Moro B; Epiceno AM; Martiradonna M; Caravita T; Santinelli S; Adorno G; Picardi A; Zinno F; Lanti A; Bruno A; Suppo G; Franchi A; Franconi G; Amadori S
Bone Marrow Transplant; 1999 Nov; 24(9):1019-27. PubMed ID: 10556963
[TBL] [Abstract][Full Text] [Related]
33. Evidence that donor intrinsic response to G-CSF is the best predictor of acute graft-vs-host disease following allogeneic peripheral blood stem cell transplantation.
Dhédin N; Chamakhi I; Perreault C; Roy DC; Sauvageau G; Ducruet T; Busque L; Fish D; Bélanger R; Roy J
Exp Hematol; 2006 Jan; 34(1):107-14. PubMed ID: 16413397
[TBL] [Abstract][Full Text] [Related]
34. Actual or ideal body weight to calculate CD34+ cell dose in patients undergoing autologous hematopoietic SCT for myeloma?
Singh V; Krishnamurthy J; Duffey S; Meagher R; Villa M; Monreal J; Evens A; Frankfurt O; Altman J; Gordon L; Tallman M; Williams S; Winter J; Singhal S; Mehta J
Bone Marrow Transplant; 2009 Feb; 43(4):301-5. PubMed ID: 18836491
[TBL] [Abstract][Full Text] [Related]
35. Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation.
Kiss JE; Rybka WB; Winkelstein A; deMagalhaes-Silverman M; Lister J; D'Andrea P; Ball ED
Bone Marrow Transplant; 1997 Feb; 19(4):303-10. PubMed ID: 9051238
[TBL] [Abstract][Full Text] [Related]
36. Telomere length changes in patients undergoing hematopoietic stem cell transplantation.
Lee J; Kook H; Chung I; Kim H; Park M; Kim C; Nah J; Hwang T
Bone Marrow Transplant; 1999 Aug; 24(4):411-5. PubMed ID: 10467331
[TBL] [Abstract][Full Text] [Related]
37. Clearance kinetics of CD34+ cells from peripheral blood: an independent predictor of hematologic recovery after high-dose chemotherapy and hematopoietic stem cell transplantation.
D'Hondt L; Wuu J; André M; Lerberghe C; Guillaume T; Feyens AM; Humblet Y; Dromelet A; Chatelain B; Longueville J; Stewart F; D'Hondt V; Symann M
Bone Marrow Transplant; 1999 Sep; 24(5):483-9. PubMed ID: 10482931
[TBL] [Abstract][Full Text] [Related]
38. The impact of CD34+ cell dose on platelet engraftment in pediatric patients following unmanipulated haploidentical blood and marrow transplantation.
Chang YJ; Xu LP; Liu DH; Liu KY; Han W; Chen YH; Wang Y; Chen H; Wang JZ; Zhang XH; Zhao XY; Huang XJ
Pediatr Blood Cancer; 2009 Dec; 53(6):1100-6. PubMed ID: 19743519
[TBL] [Abstract][Full Text] [Related]
39. Dendritic cell recovery after autologous stem cell transplantation.
Damiani D; Stocchi R; Masolini P; Michelutti A; Sperotto A; Geromin A; Skert C; Cerno M; Michieli M; Baccarani M; Fanin R
Bone Marrow Transplant; 2002 Sep; 30(5):261-6. PubMed ID: 12209346
[TBL] [Abstract][Full Text] [Related]
40. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
